From Concept to Modality: Five Years That Have Reshaped the ADC Landscape
- Summary of the advancement in the last five years: Explore how ADCs have evolved into platform innovations, mirrored by surge in strategic global licensing and mergers and acquisitions
- Key ADC success driving the field: Discuss the clinical results that have reinforced therapeutic index and tumor biology -not potency alone-, driving success and deal value
- Industry shaping: Discover how large pharma will scale and commercialize ADCs, while small biotechs will continue to fuel platform and early-stage innovation